悪性胸膜中皮腫は、高いレベルのアスベストに暴露された人に見られる稀な癌です。悪性腫瘍によって、胸膜（肺と胸郭の内側を覆う滑らかな薄い細胞膜）が影響を受けます。腹膜中皮腫は腹部に起源するため、腹痛、体重減少、悪心、嘔吐がよく見られます。貧血、腸閉塞、胸痛、喀血なども含まれます。
目次
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Malignant Mesothelioma - Overview
Malignant Mesothelioma - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Malignant Mesothelioma - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Malignant Mesothelioma - Companies Involved in Therapeutics Development
Malignant Mesothelioma - Drug Profiles
Malignant Mesothelioma - Dormant Projects
Malignant Mesothelioma - Discontinued Products
Malignant Mesothelioma - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Malignant Mesothelioma, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Malignant Mesothelioma - Dormant Projects, 2022
Malignant Mesothelioma - Dormant Projects, 2022 (Contd..1)
Malignant Mesothelioma - Dormant Projects, 2022 (Contd..2)
Malignant Mesothelioma - Dormant Projects, 2022 (Contd..3)
Malignant Mesothelioma - Dormant Projects, 2022 (Contd..4)
Malignant Mesothelioma - Discontinued Products, 2022
Malignant Mesothelioma - Discontinued Products, 2022 (Contd..1)
List of Figures
Number of Products under Development for Malignant Mesothelioma, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Top 10 Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Top 10 Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022
